(Total Views: 103)
Posted On: 09/13/2022 10:25:47 AM
Post# of 89365

$SEEL News Article - Seelos Therapeutics Announces the Participation of Acadia Healthcare in the Registration Directed Study of SLS-002 (Intranasal Racemic Ketamine) for Acute Suicidal Ideation and Behavior in Patients with Major Depressive Disorder https://marketwirenews.com/news-releases/seel...49129.html


My Twitter: WhyteStocks